ScholarIQanswers from OpenAlex & ORCID
Andrew P. Ambrosy
ResearcherPublications, citations & collaboration network
Andrew P. Ambrosy is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Andrew P. Ambrosy have?
ScholarIQindexed works
Andrew P. Ambrosy has 372 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Andrew P. Ambrosy have?
ScholarIQcitation count
Andrew P. Ambrosy has 12,798 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Andrew P. Ambrosy?
ScholarIQh-index
Andrew P. Ambrosy has an h-index of 47 in OpenAlex.
What is the i10-index of Andrew P. Ambrosy?
ScholarIQi10-index
Andrew P. Ambrosy has an i10-index of 133 in OpenAlex.
What is the ORCID of Andrew P. Ambrosy?
ScholarIQorcid
The ORCID for Andrew P. Ambrosy is on the source record.
What is the OpenAlex record for Andrew P. Ambrosy?
ScholarIQopenalex
The OpenAlex for Andrew P. Ambrosy is on the source record.
What are the most-cited papers on Andrew P. Ambrosy?
ScholarIQmost cited works
The Global Health and Economic Burden of Hospitalizations for Heart Failure
Andrew P. Ambrosy, Gregg C. Fonarow, Javed Butler, Ovidiu Chioncel, Stephen J. Greene, Muthiah Vaduganathan, Savina Nodari, Carolyn S.P. Lam, Naoki Sato, Ami N. Shah, Mihai Gheorghiade
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, Ralph B. D’Agostino, Christopher B. Granger, Nigel C. Jones, Lawrence A. Leiter, Anne E Rosenberg, Kristina N. Sigmon, Matthew C. Somerville, Karl M. Thorpe, John J.V. McMurray, Stefano Del Prato, Stefano Del Prato, John J.V. McMurray, Ralph B. D’Agostino, Christopher B. Granger, Adrian F. Hernandez, Salim Janmohamed, Lawrence A. Leiter, Robert M. Califf, Rury R. Holman, David L. DeMets, Matthew C. Riddle, Shaun G. Goodman, Darren K. McGuire, Karen Alexander, Adam D. DeVore, Chiara Melloni, Chetan B. Patel, David C. M. Kong, Gerald S. Bloomfield, Matthew T. Roe, Pierluigi Tricoci, Robert W. Harrison, Renato D. Lópes, Robin Mathews, Rajendra Mehta, W. Schuyler Jones, Sreekanth Vemulapalli, Thomas J. Povsic, Zubin J. Eapen, Keith Dombrowski, Brad J. Kolls, J. Dedrick Jordan, Andrew P. Ambrosy, Stephen J. Greene, Aditya Mandawat, Jay Shavadia, Lauren B. Cooper, Abhinav Sharma, Patrícia O. Guimarães, Daniel J. Friedman, Matthew E. Wilson, Patricia Endsley, Tracy Gentry, Jeannie Collier, Kathleen Perez, K.E. James, Jennifer Roush, C. ARDEN III POPE, Christina Howell, Megan Johnson, M. Bailey, Joanna Cole, Teresa Akers, Beth Vandyne, Betsy Thomas, Jenny Rich, Susan Bartone, Gail Beaulieu, Kim Brown, Tuan Chau, Tamra Christian, Rebecca Coker, Deb Greene, Trevorlyn Haddock, Wendy Jenkins, Ghazala Haque, Marsha L. Marquess, Jean Pesarchick, Renee Rethaford, Allegra Stone, Firas Al- Kawas, Michelle A. Anderson, Robert Enns, Isaac Sinay, Chantal Mathieu, Victor Yordanov, Irene Hramiak, Martin Haluzı́k, Søren Galatius, Bruno Guerci, Michael A. Nauck, Ilias Migdalis, Choon Beng Kathryn Tan, Győző Kocsis, Andrea Giaccari, Moon Kyu Lee, Ernesto Muñoz
Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
Eric J. Velazquez, David A. Morrow, Adam D. DeVore, Carol I. Duffy, Andrew P. Ambrosy, Kevin McCague, Ricardo Rocha, Eugene Braunwald
The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction
Matthew D. Solomon, Edward McNulty, Jamal S. Rana, Thomas Leong, Catherine Lee, Sue-Hee Sung, Andrew P. Ambrosy, Stephen Sidney, Alan S. Go
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial
Andrew P. Ambrosy, Peter S. Pang, Sadiya S. Khan, Marvin A. Konstam, Gregg C. Fonarow, Brian Traver, Aldo P. Maggioni, Thomas D. Cook, K. Swedberg, John C. Burnett, Liliana Grinfeld, James E. Udelson, Faı̈ez Zannad, Mihai Gheorghiade, on behalf of the EVEREST trial investigators